• For US Healthcare Professionals
  • For Patients and Caregivers
Evrysdi™ (risdiplam) logo
  • Find a PAL
  • Instructions for Use
  • Patient Information
Prescribing Information
Safety
Search Menu Close
  • For US Healthcare Professionals
  • For Patients and Caregivers
  • About Evrysdi
    • What is Evrysdi?
    • Evrysdi Studies
    • Type 1 SMA Study Results
    • Type 2 & 3 SMA Study Results
  • Taking Evrysdi
  • Safety Information
  • Support Services
    • Support for You
    • Sign Up
    • Evrysdi Events
  • Find a PAL
  • Instructions for Use
  • Patient Information
Safety
Prescribing Information
  • Homepage
  • About Evrysdi
    • What is Evrysdi?
    • Evrysdi Studies
    • Type 1 SMA Study Results
    • Type 2 & 3 SMA Study Results
  • Taking Evrysdi
  • Safety Information
  • Support Services
    • Support for You
    • Sign Up
    • Evrysdi Events
  • Safety

Important Safety Information & Indication

See More Back to Top

What is Evrysdi?

EvrysdiTM (risdiplam) is a prescription medicine used to treat spinal muscular atrophy (SMA) in adults and children 2 months of age and older. 

It is not known if Evrysdi is safe and effective in children under 2 months of age.

  • Before taking Evrysdi, tell your healthcare provider about all of your medical conditions, including if you:
    • have liver problems
    • are pregnant or plan to become pregnant. If you are pregnant, or are planning to become pregnant, ask your healthcare provider for advice before taking this medicine. Evrysdi may harm your unborn baby.
    • are a woman who can become pregnant:
      • Before you start your treatment with Evrysdi, your healthcare provider may test you for pregnancy. Because Evrysdi may harm your unborn baby, your healthcare provider will decide if taking Evrysdi is right for you during this time
      • Talk to your healthcare provider about birth control methods that may be right for you. Use birth control while on treatment and for at least 1 month after stopping Evrysdi
    • are an adult male planning to have children: Evrysdi may affect a man’s ability to have children (fertility). If this is of concern to you, make sure to ask a healthcare provider for advice
    • are breastfeeding or plan to breastfeed. It is not known if Evrysdi passes into breast milk and may harm your baby. If you plan to breastfeed, discuss with your healthcare provider about the best way to feed your baby while on treatment with Evrysdi
  • Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine
  • You should receive Evrysdi from the pharmacy as a liquid that can be given by mouth or through a feeding tube. The liquid solution is prepared by your pharmacist. If the medicine in the bottle is a powder, do not use it. Contact your pharmacist for a replacement
  • Avoid getting Evrysdi on your skin or in your eyes. If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water
  • The most common side effects of Evrysdi include:
    • For later-onset SMA:
      • fever
      • diarrhea
      • rash
    • For infantile-onset SMA:
      • fever
      • diarrhea
      • rash
      • runny nose, sneezing, sore throat, and cough (upper respiratory infection)
      • lung infection
      • constipation
      • vomiting

These are not all of the possible side effects of Evrysdi. For more information on the risk and benefits profile of Evrysdi, ask your healthcare provider or pharmacist.

You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at 1-888-835-2555.

Please see full Prescribing Information for additional Important Safety Information.

Genentech - A Member of the Roche Group
  • Contact Us
  • Site Map
  • Privacy Policy
  • Terms & Conditions
  • Cookie Preferences

© 2021 Genentech USA, Inc. All rights reserved. This site is intended for US Residents only.

Link to Healthcare Professionals Site
Close

The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.

Cancel OK
Link to Third Party Site
Close

The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Cancel OK